Expert Review of Neurotherapeutics
Volume 21, 2021 - Issue 1
Original Research
Triptanophobia in migraine: A case-control study on the causes and consequences of the nonuse of triptans in chronic migraine patients
Enrique Martínez-Píasa Headache Unit, Neurology Department, Hospital Clínico Universitario De Valladolid, Valladolid, Spain
https://orcid.org/0000-0001-6507-9862
https://orcid.org/0000-0001-6507-9862, David García-Azorína Headache Unit, Neurology Department, Hospital Clínico Universitario De Valladolid, Valladolid, SpainCorrespondence[email protected]
https://orcid.org/0000-0002-3132-1064
https://orcid.org/0000-0002-3132-1064, Ane Minguez-Olaondob Neurology Department, Hospital Universitario De Donostia, San Sebastian, Spainhttps://orcid.org/0000-0002-7742-3920
https://orcid.org/0000-0002-7742-3920, Javier Trigoa Headache Unit, Neurology Department, Hospital Clínico Universitario De Valladolid, Valladolid, Spainhttps://orcid.org/0000-0003-1310-3386
https://orcid.org/0000-0003-1310-3386, Álvaro Sierraa Headache Unit, Neurology Department, Hospital Clínico Universitario De Valladolid, Valladolid, Spainhttps://orcid.org/0000-0002-0022-6064
https://orcid.org/0000-0002-0022-6064, Marina Ruizc Neurology Department, Hospital Universitario De Torrevieja, Alicante. Spainhttps://orcid.org/0000-0002-1508-0168
https://orcid.org/0000-0002-1508-0168 & Ángel L. Guerreroa Headache Unit, Neurology Department, Hospital Clínico Universitario De Valladolid, Valladolid, Spain;d Headache and neuropathic pain research group, Institute for Biomedical Research of Salamanca (IBSAL), Salamanca, Spain;e Department of Medicine, University of Valladolid, Valladolid, Spainhttps://orcid.org/0000-0001-7493-6002
https://orcid.org/0000-0001-7493-6002 show all